Rezolute, Inc. Files 8-K Current Report
Ticker: RZLT · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1509261
| Field | Detail |
|---|---|
| Company | Rezolute, Inc. (RZLT) |
| Form Type | 8-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, company-history
TL;DR
Rezolute filed an 8-K on Jan 14 for an event on Jan 10. Nothing major revealed yet.
AI Summary
Rezolute, Inc. filed an 8-K on January 14, 2025, reporting an event on January 10, 2025. The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Rezolute, Inc. was formerly known as AntriaBio, Inc. and FITS MY STYLE INC.
Why It Matters
This filing indicates Rezolute, Inc. is providing an update or disclosure required by the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for a current report, not indicating any immediate financial distress or significant negative events.
Key Players & Entities
- Rezolute, Inc. (company) — Registrant
- January 10, 2025 (date) — Earliest event reported
- January 14, 2025 (date) — Filing date
- AntriaBio, Inc. (company) — Former company name
- FITS MY STYLE INC (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- 001-39683 (identifier) — SEC file number
- 275 Shoreline Drive, Suite 500, Redwood City, CA 94065 (address) — Principal executive offices
FAQ
What specific event prompted this 8-K filing on January 10, 2025?
The filing does not specify the exact event that occurred on January 10, 2025, only that it is a current report filed on January 14, 2025.
What is the primary business of Rezolute, Inc.?
Rezolute, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When did Rezolute, Inc. change its name from AntriaBio, Inc.?
The date of the name change from AntriaBio, Inc. was January 14, 2013.
What is Rezolute, Inc.'s state of incorporation and fiscal year end?
Rezolute, Inc. is incorporated in Nevada and its fiscal year ends on June 30.
What is the physical address of Rezolute, Inc.'s principal executive offices?
The principal executive offices are located at 275 Shoreline Drive, Suite 500, Redwood City, CA 94065.
Filing Stats: 730 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2025-01-14 16:30:38
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share RZLT Nasdaq Capital Market
Filing Documents
- tm253210d1_8k.htm (8-K) — 28KB
- tm253210d1_ex99-1.htm (EX-99.1) — 15KB
- 0001104659-25-003460.txt ( ) — 219KB
- rzlt-20250110.xsd (EX-101.SCH) — 3KB
- rzlt-20250110_lab.xml (EX-101.LAB) — 33KB
- rzlt-20250110_pre.xml (EX-101.PRE) — 22KB
- tm253210d1_8k_htm.xml (XML) — 4KB
01
Item 7.01 Regulation FD Disclosure. On January 10, 2025, Rezolute, Inc. (the "Company") posted a pre-recorded video to detail a patient's participation in the Companys Phase 2 clinical study. The webcast is available https://rezolutestage.wpengine.com/for-patients/ , and the transcript of the video is included as Exhibit 99.1 hereto. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this Current Report on Form 8-K. The transcript contains forward looking statements. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of the Company, are generally identified by use of words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "project," "prove," "potential," "seek," "strive," "try," or future or conditional verbs such as "predict," "could," "may," "likely," "should," "will," "would," or similar expressions. The Company's ability to predict results or the actual effects of the Company's plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Readers of the transcript and viewers of the testimonial are cautioned not to place undue reliance on these forward-looking statements, which speak only as an individual patient. Except as required by applicable law or regulation, the Company undertakes no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made. Important factors that
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Rezolute, Inc. Transcript of the Video, dated January 10, 2025 104 Cover Page Interactive Data File (formatted as inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REZOLUTE, INC. DATE: January 14, 2025 By: /s/ Nevan Charles Elam Nevan Charles Elam Chief Executive Officer